Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
72
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell

Ming-Jun Zheng1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Jing Wang1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Hui-Min Wang1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Ling-Ling Gao1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Xiao Li1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Wen-Chao Zhang1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Rui Gou1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Qian Guo1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Xin Nie1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Juan-Juan Liu1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
&
Bei Lin1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]Correspondence[email protected]
 show all
Pages 7745-7761 | Published online: 02 Nov 2018

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yajun Shen, Haoyue Xu, Lingyu Li, Yunping Lu, Min Zhang, Xin Huang & Xiaofei Tang. (2021) Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma. Cancer Management and Research 13, pages 5725-5737.
Read now

Articles from other publishers (8)

Ying-Hao Han, Xu-Dong Lian, Seung-Jae Lee, Wei-Long Li, Hu-Nan Sun, Mei-Hua Jin & Taeho Kwon. (2022) Regulatory effect of peroxiredoxin 1 (PRDX1) on doxorubicin-induced apoptosis in triple negative breast cancer cells. Applied Biological Chemistry 65:1.
Crossref
Nedret Kılıç, Özge Boyacıoğlu, Gamze Turna Saltoğlu, Erkut Baha Bulduk, Gökhan Kurt & Petek Korkusuz. (2022) Thioredoxin System and miR-21, miR-23a/b and let-7a as Potential Biomarkers for Brain Tumor Progression: Preliminary Case Data. World Neurosurgery 167, pages e1299-e1309.
Crossref
Sangeeta Jaiswal, Bishnu JoshiJing ChenFa WangMichael K. DameJason R. SpenceGina M. NewsomeErica L. KatzYatrik M. ShahSadeesh K. RamakrishnanGaoming LiMiki LeeHenry D. AppelmanRork KuickThomas D. Wang. (2022) Membrane Bound Peroxiredoxin-1 Serves as a Biomarker for In Vivo Detection of Sessile Serrated Adenomas . Antioxidants & Redox Signaling 36:1-3, pages 39-56.
Crossref
Mingxing Xu, Jianliang Xu, Dun Zhu, Rishun Su, Baoding Zhuang, Ruiyun Xu, Lingli Li, Shuxian Chen & Yunbiao Ling. (2021) Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma. Journal of Translational Medicine 19:1.
Crossref
Lianghe Jiao, Jing Wei, Jun Ye & Chuanmeng Zhang. (2021) Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: a Meta-Analysis of Cohort Study. Disease Markers 2021, pages 1-10.
Crossref
Qiongzhen Chen, Jinmeng Li, Xiaoning Yang, Junfeng Ma, Fanghua Gong & Yu Liu. (2020) Prdx1 promotes the loss of primary cilia in esophageal squamous cell carcinoma. BMC Cancer 20:1.
Crossref
Rajamanthrilage Kasun Madusanka, M.D. Neranjan Tharuka, W.S.P. Madhuranga, Seongdo Lee & Jehee Lee. (2020) Transcriptional modifications and the cytoprotective, DNA protective, and wound healing effects of peroxiredoxin-1 from Sebastes schlegelii. Fish & Shellfish Immunology 107, pages 73-83.
Crossref
Rui Xu, Jiadong Pan, Jie Mei & Qinglin Zhang. (2020) Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer. BioMed Research International 2020, pages 1-9.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.